๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Successful treatment with rituximab in a patient with an acquired factor V inhibitor

โœ Scribed by Agnes Lebrun; Catherine Leroy-Matheron; Jean-Benoit Arlet; Pablo Bartolucci; Marc Michel

Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
83 KB
Volume
83
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Successful treatment of acquired factor
Successful treatment of acquired factor VIII inhibitors with cyclosporin
โœ Brox, Alan G.; Laryea, Horace; Pelletier, Marc ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 11 KB ๐Ÿ‘ 1 views

The treatment of Factor VIII inhibitors remains controversial and no standard therapy exists. We describe in this report two consecutive patients with this inhibitor that responded to cyclosporin. Clinical improvement of the bleeding diathesis, a return to normal of the PTT, a decrease in the level

Acquired factor VIII inhibitors?successf
Acquired factor VIII inhibitors?successful treatment with an oral outpatient regimen
โœ Bayer, Ruthee-Lu; Lichtman, Stuart M.; Allen, Steven L.; Budman, Daniel R.; Buch ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 14 KB ๐Ÿ‘ 1 views

A rare cause of a spontaneous, life threatening coagulopathy in adults is the development of autoantibodies to factor VIII. We recently had the opportunity to treat seven patients with this disorder. After stabilization, they were given a regimen consisting of prednisone and oral cyclophosphamide. A